Saul E. Rivkin

Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205

Philip A. Philip, Jacqueline Benedetti, Christopher L. Corless et al. · Journal of Clinical Oncology · 2010 · 628 citations · Full text

Medicine, Oncology, Pharmacology +15

An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.

Karen H. Antman, John Crowley, S P Balcerzak et al. · Journal of Clinical Oncology · 1993 · 481 citations

Medicine, Oncology, Pharmacology +17

Dose response evaluation of adriamycin in human neoplasia

Laurence H. Baker, Josh Gottlieb, Saul E. Rivkin et al. · Cancer · 1977 · 386 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study.

Peter M. Ravdin, S Green, Thomas Dörr et al. · Journal of Clinical Oncology · 1992 · 365 citations

Medicine, Endocrinology, Oncology +17

CISPLATIN, METHOTREXATE AND BLEOMYCIN FOR THE TREATMENT OF CARCINOMA OF THE PENIS: A SOUTHWEST ONCOLOGY GROUP STUDY

Gabriel P. Haas, Brent A. Blumenstein, Robert G. Gagliano et al. · The Journal of Urology · 1999 · 226 citations

Medicine, Oncology, Pharmacotherapy +16